Hongqiu Pan

1.3k total citations
46 papers, 515 citations indexed

About

Hongqiu Pan is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Hongqiu Pan has authored 46 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 16 papers in Epidemiology and 16 papers in Pharmacology. Recurrent topics in Hongqiu Pan's work include Tuberculosis Research and Epidemiology (19 papers), Drug-Induced Hepatotoxicity and Protection (16 papers) and Drug Transport and Resistance Mechanisms (8 papers). Hongqiu Pan is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Drug-Induced Hepatotoxicity and Protection (16 papers) and Drug Transport and Resistance Mechanisms (8 papers). Hongqiu Pan collaborates with scholars based in China, United States and Sweden. Hongqiu Pan's co-authors include Jianming Wang, Shaowen Tang, Yongzhong Chen, Xianzhen Peng, Honggang Yi, Jianhui Wang, Xiaomin He, Yang Dai, Miaomiao Yang and Bilin Tao and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Hongqiu Pan

41 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongqiu Pan China 16 264 208 106 92 76 46 515
Shigeki Nabeshima Japan 17 130 0.5× 289 1.4× 208 2.0× 86 0.9× 80 1.1× 68 713
Atsunori Kaibara Japan 9 162 0.6× 144 0.7× 41 0.4× 70 0.8× 53 0.7× 21 513
Odin Naderer United States 12 287 1.1× 217 1.0× 55 0.5× 79 0.9× 25 0.3× 32 729
Selçuk Yaylacı Türkiye 14 285 1.1× 75 0.4× 63 0.6× 74 0.8× 82 1.1× 94 613
Jolene Kay Berg United States 13 170 0.6× 198 1.0× 69 0.7× 136 1.5× 174 2.3× 25 788
Zhiping Qian China 11 462 1.8× 182 0.9× 142 1.3× 88 1.0× 165 2.2× 25 886
Emmanuel Chigutsa United States 15 526 2.0× 237 1.1× 57 0.5× 94 1.0× 119 1.6× 28 857
Elisabetta Schiaroli Italy 15 226 0.9× 185 0.9× 137 1.3× 86 0.9× 87 1.1× 52 666
C.C. Chu Taiwan 9 287 1.1× 186 0.9× 340 3.2× 137 1.5× 113 1.5× 15 1.5k
Dinesh Jothimani India 11 437 1.7× 401 1.9× 30 0.3× 51 0.6× 161 2.1× 54 987

Countries citing papers authored by Hongqiu Pan

Since Specialization
Citations

This map shows the geographic impact of Hongqiu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongqiu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongqiu Pan more than expected).

Fields of papers citing papers by Hongqiu Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongqiu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongqiu Pan. The network helps show where Hongqiu Pan may publish in the future.

Co-authorship network of co-authors of Hongqiu Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Hongqiu Pan. A scholar is included among the top collaborators of Hongqiu Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongqiu Pan. Hongqiu Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Han, Bing, Xiaomin He, Meiling Zhang, et al.. (2024). Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury. Pharmacogenomics. 25(10-11). 451–460.
4.
Cheng, Liping, Hongqiu Pan, Xiaocui Wu, et al.. (2023). Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection. Molecular Medicine. 29(1). 153–153. 4 indexed citations
5.
6.
7.
Liu, Qiao, Hongqiu Pan, Ye Shen, et al.. (2021). Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China. American Journal of Respiratory and Critical Care Medicine. 204(3). 347–356. 25 indexed citations
8.
Pan, Hongqiu, Peng Lü, Limei Zhu, et al.. (2021). A risk score for prediction of poor treatment outcomes among tuberculosis patients with diagnosed diabetes mellitus from eastern China. Scientific Reports. 11(1). 11219–11219. 6 indexed citations
9.
Li, Zhongqi, Hongqiu Pan, Qiao Liu, Huan Song, & Jianming Wang. (2020). Comparing the performance of time series models with or without meteorological factors in predicting incident pulmonary tuberculosis in eastern China. Infectious Diseases of Poverty. 9(1). 151–151. 27 indexed citations
10.
Pan, Hongqiu, Yongzhong Chen, Xiaomin He, et al.. (2019). Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study. Scientific Reports. 9(1). 14311–14311. 11 indexed citations
11.
Wu, Juan, Chunmei Hu, Xia Zhang, et al.. (2019). <p>Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients</p>. Infection and Drug Resistance. Volume 12. 1265–1276. 15 indexed citations
12.
Zhou, Yang, Cheng Chen, Hui Jiang, et al.. (2019). High admission rates and heavy inpatient service costs of urban tuberculosis patients in eastern China. BMC Health Services Research. 19(1). 7 indexed citations
13.
Yang, Miaomiao, Hongqiu Pan, Xiaomin He, et al.. (2019). Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study. BMJ Open. 9(3). e027321–e027321. 15 indexed citations
14.
Pan, Hongqiu, Miaomiao Yang, Bilin Tao, et al.. (2019). Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity. Pharmacogenetics and Genomics. 29(4). 84–90. 4 indexed citations
15.
Mao, Xuhua, et al.. (2018). Clustering and recent transmission of <em>Mycobacterium tuberculosis</em> in a Chinese population. Infection and Drug Resistance. Volume 11. 323–330. 18 indexed citations
16.
Zhou, Ling, et al.. (2016). [Incidence and outcome of anti-tuberculosis drug-induced hepatotoxicity in tuberculosis inpatients].. PubMed. 37(7). 930–4. 2 indexed citations
17.
Lin, Feishen, Meiying Wu, Wen‐Jun Tu, et al.. (2015). A cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis treatment.. PubMed Central. 7(12). 2234–42. 8 indexed citations
18.
Shen, Ye, et al.. (2015). Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials. Infectious Diseases. 47(11). 808–819. 9 indexed citations
19.
Pan, Hongqiu, et al.. (2015). Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models. PLoS ONE. 10(5). e0126770–e0126770. 17 indexed citations
20.
Pan, Hongqiu, et al.. (2012). Polymorphisms of NOD2 and the risk of tuberculosis: a validation study in the Chinese population. International Journal of Immunogenetics. 39(3). 233–240. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeki Nabeshima Breakdown of academic impact, for papers by Atsunori Kaibara Breakdown of academic impact, for papers by Odin Naderer Breakdown of academic impact, for papers by Selçuk Yaylacı Breakdown of academic impact, for papers by Jolene Kay Berg Breakdown of academic impact, for papers by Zhiping Qian Breakdown of academic impact, for papers by Emmanuel Chigutsa Breakdown of academic impact, for papers by Elisabetta Schiaroli Breakdown of academic impact, for papers by C.C. Chu Breakdown of academic impact, for papers by Dinesh Jothimani
Rankless by CCL
2026